ProMIS Neurosciences (PMN) EPS (Basic) (QoQ) (2021 - 2026)
ProMIS Neurosciences (PMN) EPS (Basic) (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.70 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.23 Bn | 60.05 Bn | 1.37 Bn |
| 4 | Moderna | 60.16 Bn | 55.02 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.86 Bn | 28.55 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.24 Bn | 9.85 Bn | 668.28 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | ProMIS Neurosciences | 135.44 Mn | 81.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.59% |
| Mar 31, 2026 | 79.21% |
| Dec 31, 2025 | -2.49% |
| Sep 30, 2025 | 18.31% |
| Jun 30, 2025 | -37.69% |
| Mar 31, 2025 | -2,194.17% |
| Dec 31, 2024 | -102.97% |
| Sep 30, 2024 | 332.81% |
| Jun 30, 2024 | 28.69% |
| Mar 31, 2024 | 36.11% |
| Dec 31, 2023 | -52.64% |
| Sep 30, 2023 | 29.19% |
| Jun 30, 2023 | 53.38% |
| Mar 31, 2023 | -115.03% |
| Dec 31, 2022 | 564.64% |
| Sep 30, 2022 | -117.01% |
| Jun 30, 2022 | -31.04% |
| Mar 31, 2022 | -178.63% |
| Dec 31, 2021 | 87.64% |
| Sep 30, 2021 | 181.20% |